https://www.avient.com/sites/default/files/2020-05/1.-polyone-ir-presenstation-fermium-research-chemicals-conference.pdf
Microsoft PowerPoint - PolyOne Investor Presentation 5.4.20_v8
P E O P LE
P RO D U CT S P LA N E T
P E RF O R MAN C E
JVs Performance Products & Solutions Distribution Specialty
To be the world’s
premier provider of
specialized polymer
materials, services and
solutions
To be the world’s
premier provider of
specialized polymer
materials, services
and sustainable
solutions
2016 2017 2018 2019
Lightweighting Reduced Material Requirements Improved Recyclability
Renewable Energy Applications Eco-conscious Bio-derived Content
Reduced Energy Use VOC Reduction
$275M
$325M
$355M
$410M 14% Total Annual Growth
9% Organic Annual Growth
PolyOne Corporation 33
Adjusted EPS attributable to PolyOne common shareholders is calculated as follows:
2009* 2010* 2011* 2012* 2013* 2014* 2015* 2016** 2017** 2018 2018***
Q1
2019*** 2019
Q1
2020
Net income from continuing operations attributable to PolyOne
common shareholders
Joint venture equity earnings, after tax
Special items, before tax(1)
Special items, tax adjustments(1)
Adjusted net income from continuing operations attributable to
PolyOne common shareholders
$ 106.7 $ 152.5 $ 153.4 $ 53.3 $ 94.0 $ 78.0 $ 144.6 $ 166.4 $ 173.5 $ 161.1 $ 87.7 $ 22.4 $ 75.5 $ 33.1
(19.0) (14.7) (3.7) — — — — — — — — — — —
(48.7) 24.2 (48.1) 55.1 46.3 164.2 87.6 23.8 32.9 59.5 58.7 12.2 61.7 9.6
(27.2) (96.7) (24.7) (18.9) (13.7) (73.7) (58.7) (15.9) (24.8) (25.3) (25.1) (1.2) (5.9) (1.0)
$ 11.8 $ 65.3 $ 76.9 $ 89.5 $ 126.6 $ 168.5 $ 173.5 $ 174.3 $ 181.6 $ 195.3 $ 121.3 $ 33.4 $ 131.3 $ 41.7
Diluted shares 93.4 96.0 94.3 89.8 96.5 93.5 88.7 84.6 82.1 80.4 80.4 78.2 77.7 86.7
Adjusted EPS attributable to PolyOne common shareholders $ 0.13 $ 0.68 $ 0.82 $ 1.00 $ 1.31 $ 1.80 $ 1.96 $ 2.06 $ 2.21 $ 2.43 $ 1.51 $ 0.43 $ 1.69 $ 0.48
* Historical results are shown as presented in prior filings and have not been updated to reflect subsequent changes in accounting principle, discontinued operations or the related resegmentation.
** Pro forma for sale of Designed Structures and Solutions segment (DSS).
*** Pro forma for sale of Performance Products and Solutions segment (PP&S).
https://www.avient.com/sites/default/files/2021-09/olefins-brochure.pdf
These may
include:
• Achieve a percentage of all packaging that is
reusable, recyclable or compostable
• Increase the use of post-consumer recycled
(PCR) content, up to 100%
• Use lightweighting or other solutions that will
help reduce your carbon footprint
• Replace petroleum-based materials with
renewable materials such as bio-plastics
Whatever your goals, we can help you achieve them
with customized solutions based on a number of
factors.
Processing conditions can cause material properties to shift from the values stated in the information.
https://www.avient.com/sites/default/files/2022-02/Additives and Colorants for PP-R Pipe Systems Application Bulletin.pdf
Benefits include resistance to high temperatures
and corrosion, chemical stability, cost effectiveness
compared to other materials, and heat weldability
to connect different components (e.g. pipes
and fittings).
It
can have an oxidizing effect and shorten the life of
pipes made of materials susceptible to oxidization.
Processing conditions can cause material properties to shift from the values stated in the information.
https://www.avient.com/sites/default/files/2022-12/Mevopur Healthcare Colorants and Formulations for Needle Hubs Application Bulletin.pdf
KEY CHARACTERISTICS
• Manufactured at four ISO 13485 certified sites,
providing global consistency and increased
security of supply
• Documented change control beyond CAS
number, reducing risk of change
• Non-phthalate and formulated without
animal-derived substances
• Color can be combined with additives to
enhance performance and protection
REGULATORY SUPPORT
• Raw materials tested to:
- ISO 10993-1 and USP biological
evaluation
- European Pharmacopeia 3.1.3/3.1.5
(polyolefin)
- USP (polyethylene)
- ICH Q3D elemental impurities
• Registered Device Master File
• Food contact established with FDA/EU*
NOMINAL
OUTSIDE
DIAMETER OF
NEEDLE (MM)
COLOR
DESCRIPTION RAL PANTONE TRANSPARENT
PRODUCT CODE
OPAQUE
PRODUCT
CODE
0.4 Medium Grey 7035 423 C PP7M665125 PP7M665127
0.45 Brown 8017 7588 C PP8M665294 PP8M665296
0.5 Orange 2003 173 C PP2M665298 PP2M665300
0.55 Medium Purple 4005 7676 C PP4M665290 PP4M665292
0.6 Deep Blue 5010 288 C PP5M665894 PP5M665896
0.7 Black 9005 Black C PP9M664950 PP9M664952
0.8 Deep Green 6001 7483 C PP6M665687 PP6M665689
0.9 Yellow 1021 115 C PP1M665211 PP1M665213
1.1 Cream 1015 7401 C PP0M665290 PP0M665292
1.2 Pink 3015 502 C PE3M665725 PP3M665727
Healthcare use limitations apply—see below.
Processing conditions can cause material properties to shift from the values stated in the information.
It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device with all applicable laws and regulations, including
the suitability of all raw materials and components used for its manufacture.
https://www.avient.com/sites/default/files/2020-08/colormatrix-amosorb-low-haze-product-bulletin-8.5x11.pdf
In order to satisfy the demand for a circular
economy, governments are legislating increased
use of recycled material in single use packaging.
Our testing shows that
ColorMatrix Amosorb 4020G is one of the most
robust oxygen scavengers for PET rigid containers,
with negligible effect on oxygen scavenging efficacy
for the rPET grade tested, while other competitive
materials lost almost all efficacy with rPET content
as low as 20%.
Processing conditions can cause material properties to shift from the values stated in the information.
https://www.avient.com/sites/default/files/2022-09/Smartbatch Blow Molding Brochure.pdf
We’ll
work with you on solutions that help protect the
Earth’s resources, such as:
• Increase use of post-consumer recycled (PCR)
content with highly loaded colorants
• Use foaming agents to reduce material usage
• Extend product life with additives that protect
against harsh environments
• Conserve resources with solutions that enable
more efficient production; reduce part weight,
energy or material consumption; enable
faster cycle times; or provide better insulating
properties
Ready to optimize your process using
Smartbatch concentrates?
Processing conditions can cause material properties to shift from the values stated in the information.
https://www.avient.com/sites/default/files/2020-08/silicone-dispersion-technologies-brochure.pdf
CONFIDENCE IN
COLOR SOLUTIONS
With over 100 years’ experience in color design and pigment
selection, our technical experts understand materials,
applications and processes.
Processing conditions can cause material properties to shift from the values stated in the information.
Processing conditions can cause material properties to shift from the values stated in the information.
https://www.avient.com/sites/default/files/2022-12/Mevopur Colors for Ophthalmic Closures Application Bulletin_A4.pdf
KEY CHARACTERISTICS
• Manufactured at four ISO 13485 certified
manufacturing sites, providing global
consistency and increased security of supply
• Documented change control beyond CAS
number, reducing risk of change
• Non-phthalate and formulated without animal-
derived substances
• Standard concentrates in a PE carrier and
on request in PP
• Pre-colored formulations can be supplied in
specific resins selected for the application
REGULATORY SUPPORT
• Raw materials tested to:
- ISO 10993-1 and USP biological
evaluation
- European Pharmacopeia 3.1.3/3.1.5
(polyolefin)
- USP (polyethylene)
- ICH Q3D elemental impurities
• Registered Drug Master File (Type III)
• Food contact established with FDA/EU*
APPLICATION BULLETIN
DRUG TYPE COLOR
DESCRIPTION
PANTONE
REFERENCE
AVIENT PRODUCT
CODE PE BASED
Adrenergic agonist
combinations Light Green 373 C PE6M176349
Adrenergic agonists Purple 2583 C PE4M176057
Anti-infectives Tan 467 C PE8M176130
Anti-inflammatory,
nonsteroidal Grey Cool Grey 4 C PE7M176184
steroids Pink 197 C PE3M176237
Anti-inflammatory,
immunomodulators Olive Green 5763 C On request
Beta-blockers Yellow Yellow C PE1M176160
Beta-blocker combinations Dark Blue 281 C PE5M176272
Carbonic anhydrase inhibitors Orange 1585 C PE2M176089
Cytotoxic Black 6 C PL9M176008
Miotics Dark Green 348 C PE6M176267
Mydriatics and cycloplegics Red 1797 C PE3M176236
Prostaglandin analogues Turquoise 326 C PE5M176273
Healthcare use limitations apply—see below.
Processing conditions can cause material properties to shift from the values stated in the information.
It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device with all applicable laws and regulations, including
the suitability of all raw materials and components used for its manufacture.
https://www.avient.com/sites/default/files/2023-04/Colorant Chromatics Transcend Healthcare Colorants Product Bulletin.pdf
KEY CHARACTERISTICS
• Can be formulated for PESU, PPSU, and PSU
• 43 standard colors as well as custom colors
available
• Ultra-high heat resistance
• Based on raw materials pretested per ISO 10993
• Range of brilliant, vibrant colors
• Based on raw materials compliant
with food contact
• Customizable with functional additive solutions
• Based in polysulfone resins for ultra-high
performance; may be formulated for other
resin types
• Low minimum order quantities available
MARKETS AND APPLICATIONS
Transcend colorants are formulated specifically for
the healthcare market, and ideal for applications
such as:
• Dental tools and equipment
• Surgical robots
• Surgical lighting
• Diagnostic equipment
PRODUCT BULLETIN & COLOR CARD
Colors may vary from actual color shown.
Processing conditions can cause material properties to shift from the values stated in the information.
https://www.avient.com/sites/default/files/2022-12/Mevopur Laser Marking Additives Application Bulletin.pdf
KEY CHARACTERISTICS
• Designed for Nd:YAG lasers operating between
1060-1070 nm
• Available for different polymers including
PP, PE, PC, PBT, POM, ABS, MABS
• Manufactured at four ISO 13485 certified sites,
providing global consistency and increased
security of supply
• Documented change control beyond CAS
number, reducing risk of change
• Can be designed for dark marking on natural
or white/light colored background or light
marking on black/dark background
REGULATORY SUPPORT
• Raw materials tested to:
- ISO 10993-1 and USP biological
evaluation
- European Pharmacopeia 3.1.3/3.1.5
(polyolefin)
- USP (polyethylene)
- ICH Q3D elemental impurities
• Registered Drug Master File (Type III) and/or
Device Master File
• Food contact established with FDA/EU*
APPLICATION BULLETIN
* FDA/EU compliance information available upon request.
Processing conditions can cause material properties to shift from the values stated in the information.
It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device with all applicable laws and regulations, including
the suitability of all raw materials and components used for its manufacture.